Bioactive fractions from B. subtilis cultured in MOLP were subjected to analysis of their potential antifungal lipopeptides by LC–ESI-MS analysis. Approximately 200 μL of each antifungal fraction was filtered through 0.45-μm syringe filters and transferred to LC vials.